Recent Press Releases

ViiV Healthcare receives FDA approval for Triumeq®

London, UK, 22 August, 2014 – ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg)...

Evotec and Medicines For Malaria Venture announce a long-term compound management collaboration

Hamburg, Germany, and Branford, CT: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the start of a multi-year compound management agreement between Evotec (US)...

OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer

BOTHELL, Wash. and VANCOUVER, British Columbia -- OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small...

Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer PORTLAND, Ore., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical...

ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.

SAN DIEGO -- ViaCyte, Inc., a privately held regenerative medicine company announced today that it has entered into a Rights Agreement with Janssen Research & Development LLC (Janssen), one of...

Biotech Startup to Test Experimental Cancer Drug for Ebola Treatment

San Francisco, California – OncoSynergy announced the launch of a crowdfunding campaign to fund a study testing their experimental cancer drug, OS2966, for ebola infection. The growing ebola...

Cubist Announces EMA Acceptance of Ceftolozane/Tazobactam Marketing Authorization Application for Review

LEXINGTON, Mass.--Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the European Medicines Agency (EMA) has accepted for review the Company's Marketing Authorization Application...

Ipsen (IPN.PA) Appoints Cynthia Schwalm As President And CEO Of Ipsen North America

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen (Euronext:IPN; ADR:IPSEY) today announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A., responsible for all commercial and medical...

Mark S. Levine Joins Minerva Neurosciences, Inc. (NERV) As VP and General Counsel

CAMBRIDGE, Mass., Aug. 18, 2014 /PRNewswire/ -- Minerva Neurosciences (NERV), a leader in the development of new therapies to treat neuropsychiatric diseases and disorders, today announced that Mark...

Cyanotech Names Gerry Watts as Chief Operations Officer

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard "Gerry" Watts to fill a newly-created position as Chief Operations Officer, effective today....

Insulet Corporation (PODD) Appoints Timothy J. Scannell To Board Of Directors

BEDFORD, MA--(Marketwired - August 15, 2014) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced the...

Boston Therapeutics, Inc. Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. To Its Medical Advisory Board

Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has appointed noted diabetes specialist Jaime A. Davidson, M.D. to its Medical Advisory...

Premune Names Carl K. Johnson Chief Medical Officer

NEW YORK, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Premune, a development stage biopharmaceutical company focused on developing novel treatments for allergies and autoimmune-related disorders in companion...

IntelliCell BioSciences (SVFC) Adds Raymond Hill To Board Of Directors

IntelliCell BioSciences (SVFC) Adds Raymond Hill To Board Of Directors NEW YORK, NY--(Marketwired - August 21, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the...

Biogen Idec, Inc. (Massachusetts) (BIIB) Names Adriana Karaboutis EVP, Technology And Business Solutions

Biogen Idec, Inc. (Massachusetts) (BIIB) Names Adriana Karaboutis EVP, Technology And Business Solutions Biogen Idec (NASDAQ: BIIB) today announced the appointment of Adriana (Andi) Karaboutis as...

Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution

Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution MENLO PARK, Calif., Aug. 21, 2014 /PRNewswire/ -- Asterias Biotherapeutics,...

Clintrax Global, Inc. Announces Addition To Executive Team

Clintrax Global, Inc. Announces Addition To Executive Team RALEIGH, N.C., Aug. 20, 2014 /PRNewswire/ -- Clintrax Global, Inc., a worldwide provider of clinical research services located in Raleigh,...

Lion Biotechnologies, Inc. Names Elma Hawkins President And Chief Operating Officer

Lion Biotechnologies, Inc. Names Elma Hawkins President And Chief Operating Officer LOS ANGELES, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company...

Premune Names Carl K. Johnson Chief Medical Officer

Premune Names Carl K. Johnson Chief Medical Officer NEW YORK, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Premune, a development stage biopharmaceutical company focused on developing novel treatments for...

NeuroDerm Secures $16 Million Financing Round

REHOVOT, Israel, August 21, 2014 -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive...